Search

Search Constraints

You searched for: Author/Creator Nishiwaki, Kaichi

Search Results

2. Clinical significance of granule‐containing myeloma cells in patients with newly diagnosed multiple myeloma. (13th October 2016)

3. Dasatinib cessation after deep molecular response exceeding 2 years and natural killer cell transition during dasatinib consolidation. Issue 1 (29th November 2017)

5. Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial. Issue 12 (December 2021)

6. Optimal treatment strategy with nilotinib for patients with newly diagnosed chronic‐phase chronic myeloid leukemia based on early achievement of deep molecular response (MR4.5): The phase 2, multicenter N‐Road study. (6th April 2020)

7. Silent NK/T cell reactions to dasatinib during sustained deep molecular response before cessation are associated with longer treatment‐free remission. Issue 8 (26th June 2020)

8. Successful bridge therapy of gilteritinib to cord blood transplantation in relapsed acute myeloid leukemia after bone marrow transplantation. Issue 4 (April 2021)

9. Tandem autologous stem cell transplantation in elderly patients with myeloma: A multicenter retrospective analysis. (17th January 2023)

10. Tandem autologous versus autologous/allogeneic transplantation for multiple myeloma: propensity score analysis. Issue 9 (1st September 2016)